Median Technologies Launches Imaging Lab, Spearheading the Integration of iBiopsy Artificial Intelligence Technologies Into iCRO Imaging Services for…
SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News:
Median Technologies (Paris:ALMDT) announces that the company is expanding its portfolio of services with Imaging Lab, a new entity whose mission is to leverage AI, data mining, and radiomics technologies to exploit imaging data from clinical trials in oncology.
The creation of Imaging Lab materializes the convergence of iCRO's activities for image management in the development of new oncologic drugs and iBiopsy's activities for the development of software as medical device targeting early diagnosis of cancers, especially lung cancer.
"We are seeing a paradigm shift of pharmaceutical companies towards new drug candidates targeting patients with early-stage cancers," said Fredrik Brag, CEO and founder of Median Technologies. "The synergy between our iCRO and iBiopsy businesses is perfect to respond to this change: iBiopsy develops software as medical device, integrating AI technologies, which allow the diagnosis of diseases at a very early stage, when patients are still asymptomatic. At the same time, iCRO has extensive knowledge of image processing and its management in clinical trials. The cross-fertilization of our two businesses will enable us to leverage imaging data in conjunction with other clinical information in an unparalleled way and provide biopharmaceutical companies with tools for Go/No-Go decisions in trials," adds Fredrik Brag.
Imaging Lab will provide new answers in four areas that determine the success of clinical trials: selection of patients included in trials, especially inclusion of patients diagnosed at early stages of disease thanks to AI technologies, prediction of response to therapy, measurement of disease progression, and evaluation of the safety of drug candidates. The goal is to optimize development plans, including facilitating Go/No-Go decisions to increase the success rate of clinical trials. This rate is especially low in oncology, generating an average development cost of $2.8 billion to take a new molecule to market, compared with an average of $1 billion per new molecule brought to market for other therapeutic areas1.
"Our experience of image management in clinical trials has shown that trial data is vastly underutilized. We can extract much more information from images through the widescale use of data mining, AI, and radiomics and use these technologies to better support our customers and biopharmaceutical partners in their clinical developments," says Nicolas Dano, COO iCRO of Median Technologies.
The Imaging Lab team will be present from June 4-6 (exhibition dates) at the ASCO Annual Conference in Chicago , Medians booth #2098, Exhibit Hall A, to meet the pharmaceutical community.
About Median Technologies: Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and iBiopsy, our AI-powered software as medical device help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.
Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label Innovative company by the BPI and is listed on Euronext Growth market (Paris). FR0011049824 ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME), is part of the Enternext PEA-PME 150 index and has been awarded the Euronext European Rising Tech label. For more information: http://www.mediantechnologies.com
1 https://www.biopharmadive.com/news/new-drug-cost-research-development-market-jama-study/573381/
- Impact of Artificial Intelligence (AI) on Media and Creative Industries - EDMO - March 1st, 2025 [March 1st, 2025]
- 1 Artificial Intelligence (AI) Stock That Could Be Bigger Than Nvidia in 5 Years - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- This Artificial Intelligence (AI) Stock Is Up 15% in 2025 Already. It Is Still a Solid Buy? - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Can artificial intelligence be the future solution to the enormous challenges and suffering caused by Schizophrenia? - Nature.com - March 1st, 2025 [March 1st, 2025]
- Applications of Artificial Intelligence in Medical Education: A Systematic Review - Cureus - March 1st, 2025 [March 1st, 2025]
- This Artificial Intelligence (AI) Stock Is Up 15% in 2025 Already. It Is Still a Solid Buy? - AOL - March 1st, 2025 [March 1st, 2025]
- Federal Executive Forum Artificial Intelligence Strategies in Government Progress and Best Practices 2025 - Federal News Network - March 1st, 2025 [March 1st, 2025]
- Introduction to Artificial Intelligence for General Surgeons: A Narrative Review - Cureus - March 1st, 2025 [March 1st, 2025]
- How is Artificial Intelligence Affecting Health Care? - Workers Comp Forum - March 1st, 2025 [March 1st, 2025]
- 1 Spectacular Artificial Intelligence (AI) Stock to Buy With $50 Right Now - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- 20+ Advantages and Disadvantages of AI | Pros of Artificial Intelligence - Simplilearn - March 1st, 2025 [March 1st, 2025]
- Prediction: This Top Artificial Intelligence (AI) Stock Will Start Skyrocketing After March 6 - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- 1 Surprising Stock Harnessing the Power of Artificial Intelligence (AI) - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- 2 Top Artificial Intelligence (AI) Stocks to Buy On the Dip Amid Nasdaq Selloff - Yahoo Finance - March 1st, 2025 [March 1st, 2025]
- Review: Artificial intelligence is shaping the future of diabetes care - News-Medical.Net - March 1st, 2025 [March 1st, 2025]
- Prediction: This Artificial Intelligence (AI) Stock -- a 1,020% Gainer Since Its IPO -- Won't Split Its Stock in 2025. Here's Why - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- A Nobel laureate on the economics of artificial intelligence - MIT Technology Review - March 1st, 2025 [March 1st, 2025]
- Prediction: This Top Artificial Intelligence (AI) Stock Will Start Skyrocketing After March 6 - Nasdaq - March 1st, 2025 [March 1st, 2025]
- Meta Platforms Just Caused This Crucial Artificial Intelligence (AI) Stock to Plummet. Should You Buy the Dip? - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Artificial Intelligence - AI Update, February 28, 2025: AI News and Views From the Past Week - MarketingProfs.com - March 1st, 2025 [March 1st, 2025]
- The Ultimate Artificial Intelligence (AI) ETF to Buy With $50 Right Now - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Prediction: This Artificial Intelligence (AI) Company Will Split Its Stock in 2025 - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Should You Forget Nvidia and Buy 2 Artificial Intelligence (AI) Stocks Instead? - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Why Artificial Intelligence Stocks SoundHound AI, IonQ, and C3.ai Are Struggling Today - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- 2 Top Artificial Intelligence (AI) Stocks Ready for a Bull Run - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- AI Cant Do This Anymore: The Dangers of Artificial Intelligence in Academia - Skidmore News - March 1st, 2025 [March 1st, 2025]
- Whats Next in Artificial Intelligence: Agents that can do more than chatbots - Pittsburgh Post-Gazette - February 9th, 2025 [February 9th, 2025]
- Geopolitics of artificial intelligence to be focus of major summit in Paris; AP explains - Yahoo - February 9th, 2025 [February 9th, 2025]
- Geopolitics of artificial intelligence to be focus of major summit in Paris; AP explains - The Associated Press - February 9th, 2025 [February 9th, 2025]
- 3 Top Artificial Intelligence Stocks to Buy in February - MSN - February 9th, 2025 [February 9th, 2025]
- Geopolitics of artificial intelligence to be focus of major summit in Paris; AP explains - Lufkin Daily News - February 9th, 2025 [February 9th, 2025]
- 2 of the Hottest Artificial Intelligence (AI) Stocks on the Planet Can Plunge Up to 94%, According to Select Wall Street Analysts - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- These 2 Stocks Are Leading the Data Center Artificial Intelligence (AI) Trend, but Are They Buys Right Now? - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Book Review | Genesis: Artificial Intelligence, Hope, and the Human Spirit - LSE - February 9th, 2025 [February 9th, 2025]
- The Artificial Intelligence Action Summit In France: Maintaining The Dialogue On Global AI Regulation - Forrester - February 9th, 2025 [February 9th, 2025]
- Is prediction the next frontier for artificial intelligence? - Healthcare IT News - February 9th, 2025 [February 9th, 2025]
- The Artificial Intelligence in Medicines Market Is Set to Reach $18,119 Million | CAGR of 49.6% - openPR - February 9th, 2025 [February 9th, 2025]
- Geopolitics of artificial intelligence to be focus of major summit in Paris; AP explains - The Audubon County Advocate Journal - February 9th, 2025 [February 9th, 2025]
- Around and About with Richard McCarthy: Asking AI about itself: Will artificial intelligence ever surpass humankind? - GazetteNET - February 9th, 2025 [February 9th, 2025]
- Will the Paris artificial intelligence summit set a unified approach to AI governanceor just be another conference? - Bulletin of the Atomic... - February 9th, 2025 [February 9th, 2025]
- Apple Stock Jumps on Artificial Intelligence (AI) Driving iPhone Sales. Here's Why It's Not Getting Crushed by the DeepSeek Launch. - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Who will win the race to Artificial General Intelligence? - The Indian Express - February 9th, 2025 [February 9th, 2025]
- Prediction: This Artificial Intelligence (AI) Chip Stock Will Win Big From DeepSeek's Feat - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Prediction: 2 Artificial Intelligence (AI) Stocks That Will Be Worth More Than Nvidia 3 Years From Now - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- State of Louisiana Launches Innovation Brand, Announces Creation of $50 Million Growth Fund and Artificial Intelligence Research Institute - Louisiana... - February 9th, 2025 [February 9th, 2025]
- Using smart technologies and artificial intelligence in food packaging can reduce food waste - Yahoo News Canada - February 9th, 2025 [February 9th, 2025]
- BigBear.ai Wins Department of Defense Contract to Prototype Near-Peer Adversary Geopolitical Risk Analysis for Chief Digital and Artificial... - February 9th, 2025 [February 9th, 2025]
- Should Investors Change Their Artificial Intelligence (AI) Investment Strategy After the DeepSeek Launch? - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- 1 Unstoppable Artificial Intelligence (AI) Stock to Buy Before It Punches Its Ticket to the $4 Trillion Club - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Got 10 Years and $1000? These 3 Artificial Intelligence (AI) Stocks Are Set to Soar. - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- 1 Artificial Intelligence (AI) Stock Down 33% to Buy Hand Over Fist, According to Wall Street - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Rihanna Calls Out Use of Artificial Intelligence on Her Voice to Doctor a Clip of Her Speaking - Billboard - February 9th, 2025 [February 9th, 2025]
- 3 Best Artificial Intelligence (AI) Stocks to Buy in February - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Buying This Top Artificial Intelligence (AI) Stock Looks Like a No-Brainer Right Now - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Is Arm Stock a Buy After the Artificial Intelligence (AI) Chip Designer Released Its Quarterly Earnings Report? - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Artificial Intelligence, the Academy, And A New Studia Humanitatis - Minding The Campus - February 9th, 2025 [February 9th, 2025]
- The Trump Administrations Artificial Intelligence Rollback Is a Chance to Rethink AI Policy - Ms. Magazine - February 5th, 2025 [February 5th, 2025]
- Workday layoffs: California-based company lays off 1,750 employees, 8.5% of its workforce in favor of artificial intelligence - ABC7 Los Angeles - February 5th, 2025 [February 5th, 2025]
- It can really transform lives: Navigating the ethical landscape of artificial intelligence - WKMG News 6 & ClickOrlando - February 5th, 2025 [February 5th, 2025]
- Legal Restrictions Governing Artificial Intelligence in the Workplace - Law.com - February 5th, 2025 [February 5th, 2025]
- Google drops AI weapons banwhat it means for the future of artificial intelligence - VentureBeat - February 5th, 2025 [February 5th, 2025]
- MPs to scrutinise use of artificial intelligence in the finance sector - ComputerWeekly.com - February 5th, 2025 [February 5th, 2025]
- Catalyzing Change: Innovation and Efficiency through Artificial Intelligence in Contracting - United States Army - February 5th, 2025 [February 5th, 2025]
- STSD to hear cost breakdown, address artificial intelligence in education - The Wellsboro Gazette - February 5th, 2025 [February 5th, 2025]
- OECD activities during the Artificial Intelligence (AI) Action Summit - OECD - February 5th, 2025 [February 5th, 2025]
- Tether Ventures Into Artificial Intelligence With New Application Suite - Bitcoin.com News - February 5th, 2025 [February 5th, 2025]
- Will Artificial Intelligence Kill Acting? Nicholas Cage Thinks It Could - Movieguide - February 5th, 2025 [February 5th, 2025]
- 3 Reasons to Buy This Artificial Intelligence (AI) Stock on the Dip - The Motley Fool - February 5th, 2025 [February 5th, 2025]
- 1 No-Brainer Artificial Intelligence (AI) Stock to Buy With $35 and Hold for the Long Run - The Motley Fool - February 5th, 2025 [February 5th, 2025]
- Google renounces its promise not to develop weapons with artificial intelligence - Mezha.Media - February 5th, 2025 [February 5th, 2025]
- DeepSeek Just Changed Generative Artificial Intelligence (AI) Forever. 2 Surprising Winners From Its Innovation. - The Motley Fool - February 5th, 2025 [February 5th, 2025]
- FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare - The BMJ - February 5th, 2025 [February 5th, 2025]
- DeepSeek Just Exposed the Biggest Flaw of the Artificial Intelligence (AI) Revolution - The Motley Fool - February 5th, 2025 [February 5th, 2025]
- Artificial Intelligence Is Here: How The Innovative Technology Is Taking Over The Stateline - WREX.com - February 5th, 2025 [February 5th, 2025]
- The Ultimate Artificial Intelligence (AI) Stocks to Buy in 2025 - The Motley Fool - February 5th, 2025 [February 5th, 2025]
- This Magnificent Artificial Intelligence (AI) Stock Has Shot Up Over 175% in Just 3 Months, and It Could Soar Higher in 2025 - The Motley Fool - February 5th, 2025 [February 5th, 2025]
- Artificial intelligence is bringing nuclear power back from the dead maybe even in California - CalMatters - February 5th, 2025 [February 5th, 2025]
- Got $5,000? These Are 3 of the Cheapest Artificial Intelligence Stocks to Buy Right Now - The Motley Fool - February 5th, 2025 [February 5th, 2025]
- Compass Capital partners with MIT Sloan School of Management on an artificial intelligence project - ZAWYA - February 5th, 2025 [February 5th, 2025]
- 3 No-Brainer Artificial Intelligence (AI) Stocks to Buy With $500 Right Now - The Motley Fool - February 5th, 2025 [February 5th, 2025]